Sound regulatory systems are critical for protecting public health against use of medical
products which do not meet international standards of quality, safety and efficacy. This …

Meningococcal disease remains an important cause of morbidity and death worldwide
despite the development and increasing implementation of effective vaccines. Elimination of …

Objectives To examine the impact of use of rapid diagnostic tests for malaria on prescribing
of antimicrobials, specifically antibiotics, for acute febrile illness in Africa and Asia. Design …

Background Meningococcal disease continues to be a global public health concern due to
its epidemic potential, severity, and sequelae. The global epidemiological data on …

Invasive meningococcal disease remains a substantial global public health burden despite
being vaccine-preventable worldwide. More than one million cases are reported annually …

Background The multicomponent meningococcal serogroup B vaccine (4CMenB) is
currently indicated for active immunization against invasive meningococcal disease caused …

In the African meningitis belt, a region of sub-Saharan Africa comprising 22 countries from
Senegal in the west to Ethiopia in the east, large epidemics of serogroup A meningococcal …

Neisseria meningitidis (the meningococcus) is a member of the normal nasopharyngeal
microbiome in healthy individuals, but can cause septicemia and meningitis in susceptible …

Introduction COVID-19 vaccines are now being distributed to low-and middle-income
countries (LMICs), with global urgency surrounding national vaccination plans. LMICs have …

Objectives Neisseria meningitidis is the major cause of seasonal meningitis epidemics in the
African meningitis belt. In the changing context of a reduction in incidence of serogroup A …